Home › Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update
 

Keywords :   


Tracking Dan Loeb's Third Point Portfolio - Q4 2014 Update

2015-02-17 12:02:08| Biotech - Topix.net

Loeb's 13F portfolio increased ~27% this quarter from $8.71B to $11.09B. The number of positions decreased from 41 to 40. Third Point substantially increased large stakes in Actavis plc, Alibaba Group, Amgen Inc., and eBay Inc. while reducing Dow Chemical and Ally Financial.

Tags: point update dan portfolio

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
26.06LG and Blacknut provide cloud video games through webOS
26.06Universal UK resort to open 365 days a year
26.06Steelwork closures' ripple effect on town's wages
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
More »